Superoxide-dependent uptake of vitamin C in human glioma cells

Journal of Neurochemistry

Volumn 127, Issue 6, 2013, Pages 793-804

  Rodríguez, Federico S ^a   Salazar, Katterine A ^a   Jara, Nery A ^a   García Robles, María A ^a   Pérez, Fernando ^b   Ferrada, Luciano E ^a   Martínez, Fernando ^a   Nualart, Francisco J ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b Hospital Regional de Concepcion Dr Guillermo Grant Benavente   (Chile)

Author keywords

glioblastoma; GLUT; microglia; SVCT2; vitamin C

Indexed keywords

ASCORBIC ACID; CARRIER PROTEIN; DEHYDROASCORBIC ACID; DEHYDROASCORBIC ACID TRANSPORTER; DEOXYGLUCOSE; GLUCOSE TRANSPORTER 1; SODIUM ASCORBIC ACID COTRANSPORTER; SODIUM ASCORBIC ACID COTRANSPORTER 2; SUPEROXIDE; UNCLASSIFIED DRUG;

ARTICLE; BYSTANDER EFFECT; CANCER GRADING; CELL INFILTRATION; CELL INTERACTION; CELL STRAIN; CELL STRAIN HL60; CELL STRAIN TC620; CELLULAR DISTRIBUTION; COCULTURE; CONTROLLED STUDY; DRUG MECHANISM; EXTRACELLULAR CALCIUM; GLIOMA CELL; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; METABOLIC RATE; MICROGLIA; NERVE CELL STIMULATION; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

EID: 84890016591     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12365     Document Type: Article

References (53)

1. Angelow S., Haselbach M., and, Galla H. J., (2003) Functional characterisation of the active ascorbic acid transport into cerebrospinal fluid using primary cultured choroid plexus cells. Brain Res. 988, 105-113.
2. Astuya A., Caprile T., Castro M., et al,. (2005) Vitamin C uptake and recycling among normal and tumor cells from the central nervous system. J. Neurosci. Res. 79, 146-156.
3. Bao S., Wu Q., McLendon R. E., Hao Y., Shi Q., Hjelmeland A. B., Dewhirst M. W., Bigner D. D., and, Rich J. N., (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756-760.
4. Cameron E., and, Pauling L., (1976) Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc. Natl Acad. Sci. USA 73, 3685-3689.
5. Cameron E., and, Pauling L., (1978) Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. Proc. Natl Acad. Sci. USA 75, 4538-4542.
6. Chan W. Y., Kohsaka S., and, Rezaie P., (2007) The origin and cell lineage of microglia: new concepts. Brain Res. Rev. 53, 344-354.
7. Chen Q., Espey M. G., Sun A. Y., et al,. (2007) Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci U S A. 104, 8749-8754.
8. Deves R., and, Krupka R. M., (1978) Cytochalasin B and the kinetics of inhibition of biological transport: a case of asymmetric binding to the glucose carrier. Biochim. Biophys. Acta 510, 339-348.
9. Dheen S. T., Kaur C., and, Ling E. A., (2007) Microglial activation and its implications in the brain diseases. Curr. Med. Chem. 14, 1189-1197.
10. Dohrmann G. J., Farwell J. R., and, Flannery J. T., (1976) Glioblastoma multiforme in children. J. Neurosurg. 44, 442-448.
11. Galbiati F., Volonte D., Minetti C., Chu J. B., and, Lisanti M. P., (1999) Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex. J. Biol. Chem. 274, 25632-25641.
12. Garcia Mde L., Salazar K., Millan C., et al,. (2005) Sodium vitamin C cotransporter SVCT2 is expressed in hypothalamic glial cells. Glia 50, 32-47.
13. Garcia M. A., Millan C., Balmaceda-Aguilera C., et al,. (2003) Hypothalamic ependymal-glial cells express the glucose transporter GLUT2, a protein involved in glucose sensing. J. Neurochem. 86, 709-724.
14. Godoy A., Ulloa V., Rodriguez F., et al,. (2006) Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues. J. Cell. Physiol. 207, 614-627.
15. Guaiquil V. H., Farber C. M., Golde D. W., and, Vera J. C., (1997) Efficient transport and accumulation of vitamin C in HL-60 cells depleted of glutathione. J. Biol. Chem. 272, 9915-9921.
16. Haugeto O., Ullensvang K., Levy L. M., Chaudhry F. A., Honore T., Nielsen M., Lehre K. P., and, Danbolt N. C., (1996) Brain glutamate transporter proteins form homomultimers. J. Biol. Chem. 271, 27715-27722.
17. Heaney M. L., Gardner J. R., Karasavvas N., Golde D. W., Scheinberg D. A., Smith E. A., and, O'Connor O. A., (2008) Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs. Cancer Res. 68, 8031-8038.
18. Hong M., Xu W., Yoshida T., Tanaka K., Wolff D. J., Zhou F., Inouye M., and, You G., (2005) Human organic anion transporter hOAT1 forms homooligomers. J. Biol. Chem. 280, 32285-32290.
19. Hresko R. C., and, Hruz P. W,. (2011) HIV protease inhibitors act as competitive inhibitors of the cytoplasmic glucose binding site of GLUTs with differing affinities for GLUT1 and GLUT4. PLoS ONE 6, e25237.
20. Kilic F., and, Rudnick G., (2000) Oligomerization of serotonin transporter and its functional consequences. Proc. Natl Acad. Sci. USA 97, 3106-3111.
21. Liang W. J., Johnson D., and, Jarvis S. M., (2001) Vitamin C transport systems of mammalian cells. Mol. Membr. Biol. 18, 87-95.
22. Linster C. L., and, Van Schaftingen E., (2007) Vitamin C. Biosynthesis, recycling and degradation in mammals. FEBS J. 274, 1-22.
23. Louis D. N., Ohgaki H., Wiestler O. D., Cavenee W. K., Burger P. C., Jouvet A., Scheithauer B. W., and, Kleihues P., (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114, 97-109.
24. Lutsenko E. A., Carcamo J. M., and, Golde D. W., (2004) A human sodium-dependent vitamin C transporter 2 isoform acts as a dominant-negative inhibitor of ascorbic acid transport. Mol. Cell. Biol. 24, 3150-3156.
25. Mangiardi J. R., and, Yodice P., (1990) Metabolism of the malignant astrocytoma. Neurosurgery 26, 1-19.
26. Manuelidis L., Yu R. K., and, Manuelidis E. E., (1977) Ganglioside content and pattern in human gliomas in culture. Correlation of morphological changes with altered gangliosides. Acta Neuropathol. 38, 129-135.
27. Mendiratta S., Qu Z. C., and, May J. M., (1998) Enzyme-dependent ascorbate recycling in human erythrocytes: role of thioredoxin reductase. Free Radic Biol Med 25, 221-228.
28. Millan C., Martinez F., Cortes-Campos C., et al,. (2010) Glial glucokinase expression in adult and post-natal development of the hypothalamic region. ASN Neuro 2, e00035.
29. Moertel C. G., Fleming T. R., Creagan E. T., Rubin J., O'Connell M. J., and, Ames M. M., (1985) High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N. Engl. J. Med. 312, 137-141.
30. Morantz R. A., Wood G. W., Foster M., Clark M., and, Gollahon K., (1979) Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors. J. Neurosurg. 50, 305-311.
31. Nakamura Y., (2002) Regulating factors for microglial activation. Biol. Pharm. Bull. 25, 945-953.
32. Nimmerjahn A., Kirchhoff F., and, Helmchen F., (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314-1318.
33. Nishie A., Ono M., Shono T., et al,. (1999) Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin. Cancer Res. 5, 1107-1113.
34. Nualart F. J., Rivas C. I., Montecinos V. P., Godoy A. S., Guaiquil V. H., Golde D. W., and, Vera J. C., (2003) Recycling of vitamin C by a bystander effect. J. Biol. Chem. 278, 10128-10133.
35. Nualart F., Castro T., Low M., et al,. (2012a) Dynamic expression of the sodium-vitamin C co-transporters, SVCT1 and SVCT2, during perinatal kidney development. Histochem. Cell Biol. 139, 233-247.
36. Nualart F., Salazar K., Oyarce K., et al,. (2012b) Typical and atypical stem cells in the brain, vitamin C effect and neuropathology. Biol. Res. 45, 243-256.
37. Ohgaki H., and, Kleihues P., (2005) Epidemiology and etiology of gliomas. Acta Neuropathol. 109, 93-108.
38. Rice M. E., (2000) Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 23, 209-216.
39. Rumsey S. C., Kwon O., Xu G. W., Burant C. F., Simpson I., and, Levine M., (1997) Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. J. Biol. Chem. 272, 18982-18989.
40. Sankarapandi S., Zweier J. L., Mukherjee G., Quinn M. T., and, Huso D. L., (1998) Measurement and characterization of superoxide generation in microglial cells: evidence for an NADPH oxidase-dependent pathway. Arch. Biochem. Biophys. 353, 312-321.
41. Sarmiento J. M., Anazco C. C., Campos D. M., Prado G. N., Navarro J., and, Gonzalez C. B., (2004) Novel down-regulatory mechanism of the surface expression of the vasopressin V2 receptor by an alternative splice receptor variant. J. Biol. Chem. 279, 47017-47023.
42. Savini I., Rossi A., Pierro C., Avigliano L., and, Catani M. V., (2008) SVCT1 and SVCT2: key proteins for vitamin C uptake. Amino Acids 34, 347-355.
43. Schiffer D., Manazza A., and, Tamagno I., (2006) Nestin expression in neuroepithelial tumors. Neurosci. Lett. 400, 80-85.
44. Seyfried T. N., (2001) Perspectives on brain tumor formation involving macrophages, glia, and neural stem cells. Perspect. Biol. Med. 44, 263-282.
45. Shinonaga M., Chang C. C., Suzuki N., Sato M., and, Kuwabara T., (1988) Immunohistological evaluation of macrophage infiltrates in brain tumors. Correlation with peritumoral edema. J Neurosurg 68, 259-265.
46. Spielholz C., Golde D. W., Houghton A. N., Nualart F., and, Vera J. C., (1997) Increased facilitated transport of dehydroascorbic acid without changes in sodium-dependent ascorbate transport in human melanoma cells. Cancer Res. 57, 2529-2537.
47. Sudo S., Tanaka J., Toku K., Desaki J., Matsuda S., Arai T., Sakanaka M., and, Maeda N., (1998) Neurons induce the activation of microglial cells in vitro. Exp. Neurol. 154, 499-510.
48. Telang S., Clem A. L., Eaton J. W., and, Chesney J., (2007) Depletion of ascorbic acid restricts angiogenesis and retards tumor growth in a mouse model. Neoplasia 9, 47-56.
49. Watkins S., and, Sontheimer H,. (2012) Unique biology of gliomas: challenges and opportunities. Trends Neurosci. 35, 546-556.
50. Wen P. Y., and, Kesari S., (2008) Malignant gliomas in adults. N. Engl. J. Med. 359, 492-507.
51. Wu X., Zeng L. H., Taniguchi T., and, Xie Q. M., (2007) Activation of PKA and phosphorylation of sodium-dependent vitamin C transporter 2 by prostaglandin E2 promote osteoblast-like differentiation in MC3T3-E1 cells. Cell Death Differ. 14, 1792-1801.
52. Yi L., Xiao H., Xu M., et al,. (2011) Glioma-initiating cells: a predominant role in microglia/macrophages tropism to glioma. J. Neuroimmunol. 232, 75-82.
53. Zhai H., Heppner F. L., and, Tsirka S. E., (2011) Microglia/macrophages promote glioma progression. Glia 59, 472-485.